1-4 of 4
Jean Marie Stassen, PhD
Close
Sort by
Journal Articles

Inhibition of VPAC1 Signaling Raises Platelet Numbers after Myelosuppressive Therapy and in GATA1 Congenital Thrombocytopenia.

Karen Peeters, Kathleen Freson, PhD, Christine Wittevrongel, Chantal Thys, Jean-Marie Stassen, PhD, Marc F. Hoylaerts, PhD, Chris Van Geet, MD PhD
Journal: Blood
Blood (2007) 110 (11): 1264.
https://doi.org/10.1182/blood.V110.11.1264.1264
Published: 2007
Journal Articles

Phase I Clinical Trial of a Novel, Long-Acting Antithrombotic Drug: A Human Monoclonal Antibody Partially Inhibiting FVIII Activity.

Peter Verhamme, MD, PhD, Steve Pakola, MD, Marc Jacquemin, MD, PhD, Jean Marie Saint-Remy, MD, PhD, Jean Marie Stassen, PhD, Desire Collen, MD, PhD, Rikke Riisbro, MD, PhD, Thomas Jensen, MD, PhD, Steven Glazer, MD
Journal: Blood
Blood (2007) 110 (11): 312.
https://doi.org/10.1182/blood.V110.11.312.312
Published: 2007
Journal Articles

Dabigatran Inhibits Arterial Thrombosis in a Porcine Model of Cyclic Flow Reduction.

Joanne van Ryn, PhD, Henning Priepke, PhD, Uwe J. Ries, PhD, Norbert Hauel, PhD, Jean-Marie Stassen, PhD, Wolfgang Wienen, PhD
Journal: Blood
Blood (2006) 108 (11): 906.
https://doi.org/10.1182/blood.V108.11.906.906
Published: 2006
Journal Articles

The Determination of the Inhibitory Activity of Some Factor VIII Type II Inhibitor Antibodies Is Biased by the Type of Factor VIII Assay.

Marc G. Jacquemin, MD, Seb Lamprecht, MSc, Renaud Lavend’homme, MSc, Jan Roodt, MSc, Bernard Chatelain, MD, Veronique Deneys, MD, Jeroen Dewaele, MSc, Jean-Marie Stassen, PhD, Muriel Meiring, PhD, Jean Marie Saint-Remy, MD, Henry Pieters, PhD, Philip Badenhorst, MD
Journal: Blood
Blood (2005) 106 (11): 3200.
https://doi.org/10.1182/blood.V106.11.3200.3200
Published: 2005